Literature DB >> 30504110

[Obstructive sleep apnea-hypopnea and stroke].

Matías Otto-Yáñez1,2,3, Rodrigo Torres-Castro1,3, Joaquín Nieto-Pino2,4, Mercedes Mayos5,6,7.   

Abstract

Stroke, one of the main causes of disability and death worldwide, is frequently associated to the obstructive sleep apnea-hypopnea syndrome. This sleep disorder has been demonstrated to be an independent risk factor for stroke, and therefore its investigation and treatment has been recommended for patients with stroke. Mechanisms relating these two clinical disorders include: oxidative stress, cerebral blood flow alterations, autonomic dysfunction, and hypercoagulability, as well as patent foramen ovale, blood pressure, and heart rhythm disorders. Increasing amount of evidence supports continuous airway positive pressure therapy in patients with stroke, but further randomized clinical trials are needed to obtain solid conclusions. This work reviews the literature on epidemiology, pathophysiology, clinical assessment, and treatment of apnea-hypopnea syndrome in patients with stroke.

Entities:  

Keywords:  continuous positive airway pressure; obstructive sleep apnea; stroke

Mesh:

Year:  2018        PMID: 30504110

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  3 in total

1.  Diagnosis of Heart Failure Complicated with Sleep Apnea Syndrome by Thoracic Computerized Tomography under Artificial Intelligence Algorithm.

Authors:  Weihong Tian; Jinghua Li; Lan Ma
Journal:  Comput Math Methods Med       Date:  2022-05-09       Impact factor: 2.809

2.  Effect of acupuncture on sleep quality and neurological function in stroke patients with sleep apnea syndrome.

Authors:  Peng Zhang; Lingsu Cheng; Qian Tian; Guang Chen; Chao Chen; Junfeng Xu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Study on the Changes of Liver and Kidney Function-Related Indicators and Clinical Significance in Patients with OSAHS.

Authors:  Rongyue Liu; Xiangdong Kong
Journal:  Emerg Med Int       Date:  2022-06-16       Impact factor: 1.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.